Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

NCT02995473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: NP000888
DRUG: Vehicle

Sponsor

Galderma R&D